Overview Financials News + Filings Key Docs Ownership Insiders
|
| In millions, except per share items | Dec-31-22 | Jan-01-22 | Jan-02-21 | Dec-28-19 | Dec-29-18 |
| | 10-K | 10-K | 10-K | 10-K | S-1/A |
| Revenues: |
| Self-pay | | | 2.2 | 4.1 | |
| Medicaid | | | 405.6 | 406.3 | |
| Medicare | | | 46.2 | 34.6 | |
| Commercial | | | 147.3 | 152.0 | |
| Other | | | 893.8 | 787.0 | |
| Total revenues | 1,787.6 | 1,678.6 | 1,495.1 | 1,384.1 | 1,253.7 |
| Revenue growth [+] | 6.5% | 12.3% | 8.0% | 10.4% | |
| Self-pay | | | -45.9% | | |
| Medicaid | | | -0.2% | | |
| Medicare | | | 33.6% | | |
| Commercial | | | -3.1% | | |
| Medicaid MCO | | | 13.6% | | |
| Cost of goods sold | 1,234.4 | 1,136.2 | 1,040.6 | 964.8 | 1,088.6 |
| Gross profit | 553.2 | 542.4 | 454.5 | 419.3 | 165.0 |
| Gross margin | 30.9% | 32.3% | 30.4% | 30.3% | 13.2% |
| Selling, general and administrative [+] | 495.1 | 427.8 | 354.8 | 341.0 | 104.5 |
| Sales and marketing | 357.2 | 297.4 | 240.9 | 227.8 | |
| General and administrative | 137.9 | 130.4 | 113.8 | 113.2 | 104.5 |
| Other selling, general and administrative | 357.2 | 297.4 | 240.9 | 227.8 | |
| Other operating expenses | 3.7 | -0.3 | 0.9 | 2.3 | 5.9 |
| EBITDA [+] | 54.5 | 115.0 | 98.8 | 75.9 | 66.5 |
| EBITDA growth | -52.6% | 16.3% | 30.2% | 14.1% | |
| EBITDA margin | 3.0% | 6.8% | 6.6% | 5.5% | 5.3% |
| Depreciation | 15.3 | 16.0 | 13.9 | 10.1 | 11.9 |
| EBITA | 39.2 | 99.0 | 84.9 | 65.8 | 54.6 |
| EBITA margin | 2.2% | 5.9% | 5.7% | 4.8% | 4.4% |
| Amortization of intangibles | 6.0 | 4.6 | 3.1 | 4.2 | |
| EBIT [+] | 33.2 | 94.4 | 81.8 | 61.6 | 54.6 |
| EBIT growth | -64.9% | 15.4% | 32.8% | 12.8% | |
| EBIT margin | 1.9% | 5.6% | 5.5% | 4.5% | 4.4% |
| Non-recurring items [+] | 675.4 | 130.5 | 85.3 | 22.7 | 15.6 |
| Asset impairment | 675.3 | 117.7 | 75.7 | | |
| Interest expense, net [+] | 107.0 | 68.7 | 82.6 | 92.1 | 74.9 |
| Interest expense | 107.7 | 68.9 | 83.0 | 92.3 | 75.5 |
| Interest income | 0.7 | 0.3 | 0.3 | 0.2 | 0.6 |
| Other income (expense), net [+] | 85.5 | -8.8 | 34.4 | -21.9 | -13.7 |
| Gain (loss) on debt retirement | | -13.7 | -0.1 | -4.9 | |
| Other | 85.5 | 4.9 | 34.5 | -17.0 | 13.7 |
| Pre-tax income | -663.8 | -113.6 | -51.7 | -75.0 | -49.7 |
| Income taxes | -1.8 | 3.5 | 5.3 | 1.5 | -2.5 |
| Tax rate | 0.3% | | | | 5.1% |
| Net income | -662.0 | -117.0 | -57.1 | -76.5 | -47.1 |
| Net margin | -37.0% | -7.0% | -3.8% | -5.5% | -3.8% |
| |
| Basic EPS [+] | ($3.57) | ($685.97) | ($0.40) | ($0.56) | ($0.36) |
| Growth | -99.5% | 169405.5% | -27.6% | 55.7% | |
| Diluted EPS [+] | ($3.57) | ($0.69) | ($0.40) | ($0.56) | ($0.36) |
| Growth | 420.1% | 69.5% | -27.6% | 55.7% | |
| |
| Shares outstanding (basic) [+] | 185.6 | 0.2 | 141.0 | 136.9 | 131.3 |
| Growth | 108649.0% | -99.9% | 3.0% | 4.3% | |
| Shares outstanding (diluted) [+] | 185.6 | 170.6 | 141.0 | 136.9 | 131.3 |
| Growth | 8.7% | 21.0% | 3.0% | 4.3% | |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|